Partner with us on cancer clinical research efforts.
We invite industry partners, sponsors, and external investigators to bring forward ideas for cutting-edge clinical trials across all cancer types. Clinical trials are research studies that evaluate new methods to prevent, diagnose, and treat cancer—helping transform scientific discoveries into better care for our patients. By submitting your study concept here, you support Holden’s mission to advance cancer research, improve patient outcomes, and expand access to innovative therapies.
Use the contact information below to share your proposal and connect with our corresponding MOG medical oncologists (by cancer type) and pre-study team for scientific and operational review.
Note: Clicking on a MOG medical oncologist's name will open an email draft addressed to that leader as well as our pre-study team.
Clinical trial intake contacts
- Breast Cancer: Sneha Phadke DO, MPH
- Central Nervous System (CNS) Cancer: Gustavo Godoy Almeida MD, PhD
- Early Phase Cancer: Douglas Laux, MD, MS
- Gastrointestinal Cancer: Saima Sharif MD, MS
- Genitourinary Cancer: Fernando Maciel Barbosa, MD
- Gynecologic Cancer: David Bender, MD and Gustavo Girotto, MD
- Head and Neck Cancer: Douglas Laux, MD, MS
- Leukemia: Prajwal Dhakal, MBBS
- Lymphoma: Eric Mou, MD
- Melanoma: Mohammed Milhem, MBBS and Hisakazu Hoshi, MD
- Multiple Myeloma: Christopher Strouse, MD
- Neuroendocrine Cancer: Joseph Dillon, MB, BCh, BAO
- Pediatric Cancer: Jenna Gedminas, MD and Sara Claire Horton, MD
- Sarcoma: Benjamin Miller MD, MS and Mohammed Milhem, MBBS
- Thoracic Cancer: Margaret Byrne MD, MSc